Breast Tumour Tissue Microarray
A breast tumour tissue microarray (TMA) is a cutting-edge tool designed to enhance the efficiency and accuracy of breast cancer research. By integrating multiple tissue samples into a single paraffin block, TMAs allow researchers to conduct high-throughput analysis with unmatched convenience. This technology plays a pivotal role in understanding breast cancer biology, enabling the study of biomarkers, breast tumor heterogeneity, and development of subtype-specific therapies.
Our Breast Tumour TMAs
MYmAb Biologics provides breast tumour tissue microarrays from Southeast Asian (SEA) samples globally. All our breast tumor TMAs are IRB-approved and fully consented. If you are looking for breast tumour TMA slides for your cancer research, visit our product pages or contact our team for a quote.
-
Breast Tumor & Adjacent Normal Tissue Microarray – MB006
Read more -
Breast Tumor Tissue Microarray (120 cases) – MBB4
Read more -
Breast Tumor Tissue Microarray (129 cases) – MBB1
Read more -
Breast Tumor Tissue Microarray (131 cases) – MBB3
Read more -
Breast Tumor Tissue Microarray (88 cases) – MBB2
Read more
Our Breast Cancer Subtype TMAs
MYmAb Biologics also provides breast cancer subtype tissue microarrays from Southeast Asian (SEA) samples globally. All our breast cancer subtype TMAs are IRB-approved and fully consented to. If you are looking for breast cancer TMA slides for your cancer research, visit our product pages or contact our team for a quote.
Benefits of Breast Tumour TMAs
Breast tumour tissue microarrays offer a powerful and efficient solution for cancer researchers, enabling the analysis of multiple tumour samples simultaneously. This approach streamlines workflows, reduces costs, and ensures consistent, high-quality data, making it an indispensable tool for advancing breast cancer studies.
- Efficiency: Evaluate hundreds of tumour samples in parallel, saving time and resources.
- Cost-Effectiveness: Reduce reagent and slide preparation costs by consolidating sample analysis.
- Reproducibility: Standardized arrays ensure consistency across experiments.
- Comprehensive Data: Study a wide range of tumour stages, subtypes, and patient demographics in one slide.
- Customizability: Tailored TMA solutions to meet specific research requirements.
Applications of Breast Tumour TMAs in Cancer Research
- Biomarker Discovery: Identify and validate biomarkers for breast cancer diagnosis, prognosis, and treatment.
- Drug Development: Evaluate drug efficacy and predict therapeutic responses using diverse tumour samples.
- Histological Studies: Explore tumour morphology and progression across a wide spectrum of cases.
- Genomic and Proteomic Analysis: Perform high-throughput molecular studies to uncover genetic and protein-level changes in breast cancer.
- Personalized Medicine Research: Support research efforts toward tailored cancer therapies based on individual patient profiles.
Why Choose Our Breast Tumour Tissue Microarray
MYmAb Biologics ethically produces human tissue microarrays (TMAs) through our ArrayZeal platform, guided by strict ethical standards and built on a foundation of precision and reliability. Each TMA is carefully constructed using clinically validated human tissue samples sourced from diverse Southeast Asian populations. This ensure better representation of ethic genetic variability, which is an important factor that influences disease progression and treatment responses. Committed to delivering reliable and reproducible results, ArrayZeal support robust scientific discoveries and accelerate translational research. By offering Southeast Asian-derived TMAs, we empower researchers to explore novel therapies within a broader genetic context, paving the way for groundbreaking discoveries and personalized medicine.
Frequently Asked Questions
Conventionally, immunohistochemical staining has been performed on whole tissue sections. However, this traditional method, which requires the processing and staining of hundreds or even thousands of slides, is time-consuming and expensive. In contrast, a TMA allows simultaneous analysis of hundreds of tissues in one go using identical conditions. Thus, TMA technology markedly conserves reagents, saves time and greatly decreases the amount of archival tissue required for a particular study, thus preserving the tissues for other diagnostic and/or research needs.
A core size of 0.6 to 2.0 mm is adequate to represent the whole tissue section.
Sometimes, a small core of sample may not be representative of the whole tumour, especially in heterogenous tumour types. To overcome this, we offer TMAs that include two to three cores of samples from different locations of a single tumour block.
Negative and positive control TMA slides should be included as they are important in ensuring the validity of the experiment.
To help with TMA orientation.
A minimum of 3 slides per TMA type to include positive and negative controls.
All patients are anonymised.
Yes. You may contact us for further details and discuss on your needs.
The TMAs are sent in ambient temperature.
We recommend you to store your TMA slides at 4°C for not more than a year.
Request for Quote
Location:
Block D-G-8, UPM-MTDC Technology Centre III, Universiti Putra Malaysia, 43400 Serdang, Selangor Darul Ehsan, Malaysia.
Phone:
03-8938 9819
Email:
info.mymab@gmail.com